Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cognition Disorder: early-phase trial registry
1 of 3 indexed Cognition Disorder trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Cognition Disorder: 3 US clinical trials tracked, 1 recruiting.
Cognition Disorder is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Harvard University Faculty of Medicine, running 1 of these trials.
Enrollment posture brief
Registry condition cognition-disorder
OPEN 1 | RECR 33% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Cognition Disorder lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cognition Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cognition Disorder is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Human Epilepsy Genetics--Neuronal Migration Disorders Study
Harvard University Faculty of Medicine
NCT00041600
DIAMOND-Lewy Guidelines for Antipsychotic Use in Older Patients
Ohio State University
NCT06357195
NeuroCognition After Carotid Recanalization
Duke University
NCT04219774
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Cognition Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cognition Disorder trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cognition Disorder page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Cognition Disorder trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Harvard University Faculty of Medicine sponsors the most Cognition Disorder trials on record, review their full trial history before evaluating a specific study. See Harvard University Faculty of Medicine's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cognition Disorder condition card totals 3 registered trials; most-linked intervention Aspirin and Clopidogrel (maximal medical Therapy); top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.